Press Releases

28

Jun, 2021

Nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini

Tags:

Università degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini Uno studio pubblicato in questi giorni sulla rivista “Paediatrics” dimostra che i bambini affetti da forme lievi di COVID-19 sviluppano una risposta anticorpale maggiore e più duratura di quella degli adulti. Lo studio ha coinvolto 57 famiglie venete colpite dal COVID 19 e seguite presso il Dipartimento Salute della Donna e del Bambino dell’Università di Padova.   Padova, 28 giugno 2021 – Ricercatori dell’Università degli Studi […]

READ MORE

1

Apr, 2019

GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

 

Geneva / Padova, Monday 4 March 2019 – The Global Antibiotic Research & Development Partnership (GARDP) and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant infections in children. The strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines. Globally, more than three million childhood deaths result from infectious diseases, such as pneumonia and sepsis (1). Children are also particularly affected by antimicrobial resistance […]

READ MORE

1

Apr, 2019

University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics

Tags: ,

Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitrodiagnostic companies who join forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. The purpose of VALUE-Dx is to transform medical practice to achieve more personalised, evidence-based antibiotic prescription and use in community care settings through the widespread use of clinical and cost-effective innovative diagnostic strategies. VALUE-Dx is co-funded […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities